Home > About Anaxomics > Management Team
Management Team
The Management Team of the Company has many years of experience in the field of drug discovery and clinical development. Our Scientific Board is composed of scientific experts from independent organizations such as universities and governmental research institutes.
Anaxomics Scientific Board
Patrick Aloy, MSc, PhD
Dr Patrick Aloy is an ICREA Research Professor and Principal Investigator of the Structural Systems Biology lab at the IRB. He obtained his BSc in Biochemistry, MSc in Biotechnology and PhD in Computational Biology by the Autonomous University of Barcelona, Spain, and spent six years as postdoctoral researcher and staff scientist at the European Molecular Biology Laboratory, Heidelberg, Germany.
For fourteen years, Dr Aloy has been developing and implementing new technologies and algorithms, applying state-of-the-art methods to specific problems and bridging the gap between theoretical models and experiments in different disciplines. Dr Aloy has over 50 publications in first-rate journals, with over 2300 citations and remarkable press coverage, illustrating the scientific and social relevance of the work.
José Manuel Mas, PhD
PhD in Biochemistry (Biocomputing)
2 Patents, 30 Scientific papers
Joan Bigorra, MD, PhD
Currently Director of Innovation at Hospital Clínic de Barcelona
Scientific Director of the Master in Leadership and Management of Science and Innovation (UB, UAB,UPF Interuniversity program, Barcelona)
Former Managing Director of Fundació Clínic per a la Recerca Biomèdica(2006-2008), Managing Director of Novartis Pharma Spain (2004-2006), COO of Novartis Pharma Spain (1997-2004).
Several key positions in R&D management in other leading Pharma Industries (Sandoz Pharma, Boehringuer Ingelheim, Bayer, Esteve) (1985-1997)
MBA by IESE
Corporate training in General Management and Finance at Harvard Business School (1999-2003)
Assistant Editor of The Lancet (Spanish edition) (1986-1996)
More than 50 publications / book chapters on R&D management and health outcomes research.
Dr Xavier Gomis
Dr. Gomis-Rüth studied organic chemistry at the Chemical Institute of Sarrià (IQS, Barcelona, Spain) and he obtained his B.Sc. (1988) and M.Sc. (1989) there before moving to the Max-Planck-Institute of Biochemistry (MPIB, Martinsried, Germany), where he made his Ph.D. in protein crystallography in the lab of 1988-Nobel laureate Robert Huber (1992).
Postdoctoral stays at the Autonomous University of Barcelona (Spain), the MPIB, and the Molecular Biology Institute of Barcelona (IBMB) of the Spanish Research Council (CSIC) followed before he got a tenured Assistant Professor position at the latter institution.
Since 2008, he is Research Professor CSIC, Director of the Department of Structural Biology of the IBMB, and Head of the Proteolysis Lab at the IBMB, which is located at the premises of the Barcelona Science Park (PCB).
The Proteolysis Lab currently encompasses nine researchers and is centered on the study of proteins by molecular and structural biology to ascertain structure-function relationships following an experimental approach.
